Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Transfusion

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1537-2995.2008.01693.xPMID 18373500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-Induced Immune Hemolytic Anemia

  2016cited by this paper
• Acute haemolytic transfusion reactions secondary to human leukocyte antigen alloimmunization

  2008cited by this paper
• Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4.

  2007cited by this paper
• Guidelines on the use of intravenous immune globulin for hematologic conditions.

  2007cited by this paper
• Hyperhemolysis syndrome in anemia of chronic disease

  2005cited by this paper
• Hyperhaemolysis Syndrome in a Patient with Myelofibrosis

  2004cited by this paper
• A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteins.

  2004cited by this paper
• Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes.

  2004cited by this paper
• Use of Intravenous Immunoglobulin and Intravenous Methylprednisolone in Hyperhaemolysis Syndrome in Sickle Cell Disease

  2004cited by this paper
• Practical management of haemoglobinopathies

  2004cited by this paper
• Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization

  2003cited by this paper
• Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

  2003cited by this paper
• The clinical features of 16 cases of stroke associated with administration of IVIg

  2003cited by this paper
• Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

  2002cited by this paper
• In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations – a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases *

  2002cited by this paper
• Intravenous gammglobulin-associated acute renal failure.

  2001cited by this paper
• Hyperhemolytic transfusion reaction in sickle cell disease

  2001cited by this paper
• Intravenous gammaglobulin‐associated acute renal failure

  2001cited by this paper
• Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin.

  2000cited by this paper
• Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications.

  2000cited by this paper
• Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.

  2000cited by this paper
• Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells

  1997cited by this paper
• The sickle cell hemolytic transfusion reaction syndrome

  1997influential reference
• The sickle cell hemolytic transfusion reaction syndrome

  1997cited by this paper
• THE SICKLE CELL HEMOLYTIC TRANSFUSION REACTION SYNDROME. AUTHORS' REPLY

  1997cited by this paper
• Severe reactions associated with transfusion of patients with sickle cell disease

  1997cited by this paper
• Alloimmunization to platelets in heavily transfused patients with sickle cell disease.

  1996cited by this paper
• Post‐Transfusion Hyperhaemolysis in a Patient with Sickle Cell Disease: Use of Steroids and Intravenous Immunoglobulin to Prevent Further Red Cell Destruction

  1995cited by this paper
• Sickle reticulocytes adhere to VCAM-1.

  1995cited by this paper
• Transfusion transmission of human T‐lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look‐back investigations

  1993cited by this paper
• Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases.

  1987cited by this paper
• Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.

  1985influential reference
• Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow.

  1982cited by this paper
• Reticulocytopenia and "absence" of red cell autoantibodies in immune haemolytic anaemia.

  1977cited by this paper
• A Haemolytic Transfusion Reaction without Demonstrable Antibodies in Vitro

  1963cited by this paper
• Haemolytic Transfusion Reaction due to Incompatibility without Demonstrable Antibodies

  1960cited by this paper
• The inhibition of erythrophagocytosis in vitro by corticosteroids.

  1960cited by this paper

• Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome

  2025cites this paper
• Hematological emergencies in intensive care unit: Recognition, management protocols, and multidisciplinary care

  2025cites this paper
• Delayed Hemolytic Transfusion Reaction With Acute Kidney Injury Due to Anti-E Antibody in a 43-Year-Old Woman With Iron-Deficiency Anemia

  2025cites this paper
• Assessing Alloimmunization in Sickle Cell Disease Patients: Insights From a Tertiary Care Center Study on Multiple Blood Transfusion Recipients in Central India

  2025cites this paper
• Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature

  2025cites this paper
• A Case Report of Hyperhemolytic Syndrome in Sickle Cell Disease, with a Special Focus on Avoiding the Use of Transfusions

  2024influential citation
• What is the role of complement in bystander hemolysis? Old concept, new insights

  2024cites this paper
• Alloimmunization and hyperhemolysis in sickle cell disease.

  2023cites this paper
• “Don’t Add Fuel to the Fire”– Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β0-Thalassemia: Case Report and Review of the Literature

  2023cites this paper
• Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review

  2022cites this paper
• Genotyping and the Future of Transfusion in Sickle Cell Disease.

  2022cites this paper
• Post-Artesunate Delayed Hemolysis in Patients with Severe Malaria in the United States-April 2019 Through July 2021.

  2022cites this paper
• Adverse events of red blood cell transfusions in patients with sickle cell disease.

  2022cites this paper
• Estudo da associação de polimorfismos em genes de resposta imune com a aloimunização eritrocitária em pacientes portadores de síndromes mielodisplásicas

  2022influential citation
• Hyperhemolytic Crisis Following Transfusion in Sickle Cell Disease With Acute Hepatic Crisis: A Case Report

  2022cites this paper
• Hyperhemolysis syndrome in a case of sickle cell disease

  2022cites this paper
• Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature

  2022cites this paper
• Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease

  2021cites this paper
• Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

  2021cites this paper
• Transfusion Reactions and Adverse Events.

  2021cites this paper
• Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab

  2021cites this paper
• Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature.

  2020cites this paper
• Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab

  2020cites this paper
• A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion

  2020cites this paper
• Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs

  2020cites this paper
• Hyperhemolysis Syndrome Following Red Cell Exchange in a Newly Diagnosed Sickle Cell Disease Patient With Spinal Cord Infarction

  2020influential citation
• Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactions.

  2020cites this paper
• American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

  2020cites this paper
• Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients

  2019cites this paper
• Hyperhaemolysis Syndrome in Sickle Cell Disease

  2019influential citation
• The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell disease.

  2019cites this paper
• Treatment of post‐transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti‐IL6R humanised monoclonal antibody Tocilizumab

  2019cites this paper
• A case‐control analysis of hyperhemolysis syndrome in adults and laboratory correlates of complement involvement

  2019cites this paper
• Successful management of the potentially fatal hyperhaemolysis syndrome of sickle cell anaemia with a regimen including bortezomib and Hemopure

  2019cites this paper
• A Differential Approach to an Uncommon Case of Acute Anemia in a Child With Sickle Cell Disease

  2019cites this paper
• Histopathological evidence for macrophage activation driving post‐transfusion hyperhaemolysis syndrome

  2019cites this paper
• Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions

  2019cites this paper
• Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.

  2019cites this paper
• Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.

  2019cites this paper
• Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors

  2018cites this paper
• A man with fever and haemoglobinuria after blood transfusion

  2018cites this paper
• Hyperhemolysis Syndrome in Patients With Sickle Cell Disease.

  2018cites this paper
• Hyperhemolysis syndrome: theory and practice

  2018cites this paper
• How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

  2018cites this paper
• Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects

  2017cites this paper
• Hyperhemolysis with hemoglobin H disease

  2017cites this paper
• Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease

  2017cites this paper
• Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease

  2017cites this paper
• Fatal Delayed Hemolytic Transfusion Reaction and Hyperhemolysis without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Case Report and Literature Review

  2017cites this paper
• Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.

  2017cites this paper
• A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease

  2017cites this paper
• Crises in Sickle Cell Disease.

  2016cites this paper
• A Case of Hyperhemolytic Anemia

  2016cites this paper
• Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series

  2016cites this paper
• Anti‐HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients

  2016cites this paper
• Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease

  2016cites this paper
• Transfusion reactions: prevention, diagnosis, and treatment.

  2016cites this paper
• Management of hyperhaemolysis after a transfusion in sickle‐cell patients

  2016cites this paper
• Delayed hemolytic transfusion reaction in adult sickle‐cell disease: presentations, outcomes, and treatments of 99 referral center episodes

  2016cites this paper
• Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia

  2016cites this paper
• Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature.

  2015influential citation
• Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab

  2015cites this paper
• Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion

  2015cites this paper
• The five key things you need to know to manage adult patients with sickle cell disease.

  2015cites this paper
• Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival

  2015cites this paper
• Hyperhemolysis Syndrome without Underlying Hematologic Disease

  2015cites this paper
• Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease

  2015cites this paper
• Life‐threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab

  2015influential citation
• [Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network].

  2015cites this paper
• Hyperhaemolysis in a patient with HbH disease

  2014influential citation
• Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing

  2014cites this paper
• Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.

  2014cites this paper
• Transfusion et drépanocytose : axes d’optimisation de la sécurité transfusionnelle

  2014cites this paper
• Hyperhemolysis in Sickle Cell Disease

  2014cites this paper
• How we incorporate molecular typing of donors and patients into our hospital transfusion service

  2014cites this paper
• [Transfusion and sickle cell disease: axes of transfusion safety optimization].

  2014cites this paper
• Relevance of blood groups in transfusion of sickle cell disease patients.

  2013cites this paper
• Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease

  2013cites this paper
• The role of blood transfusion in Sickle Cell Disease

  2013cites this paper
• Enfermedad de células falciformes: papel del pediatra

  2013cites this paper
• Delayed hemolytic transfusion reaction, intravenous immunoglobulin, and rituximab

  2013cites this paper
• Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma‐to‐red blood cell exchange transfusion

  2013cites this paper
• Stem cell‐derived erythrocytes as upcoming players in blood transfusion

  2013cites this paper
• Sickle Cell Disease

  2012cites this paper
• Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report

  2012cites this paper
• [Red blood cell immunization in haemoglobinopathie: about 84 cases].

  2012cites this paper
• Transfusion in Sickle Cell Disease: A Systematic Review of Benefits, Complications, and Management of Complications, 2012

  2012cites this paper
• Alternative Blood Products and Clinical Needs in Transfusion Medicine

  2012cites this paper
• Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

  2012cites this paper
• A life‐threatening episode of treatment‐resistant haemolysis in a pregnant patient with dyserythropoietic anaemia (CDA) type I

  2012cites this paper
• Hyperhaemolysis syndrome treated with corticosteroids and darbopoietin in a patient with mantle cell lymphoma

  2012cites this paper
• Ex Vivo Generated Red Cells as Transfusion Products

  2012cites this paper
• The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells

  2012cites this paper
• WHAT DO WE MEAN BY “HYPERHAEMOLYSIS” AND WHAT IS THE CAUSE?

  2012cites this paper
• Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.

  2012cites this paper
• Concise Review: Stem Cell‐Derived Erythrocytes as Upcoming Players in Blood Transfusion

  2012cites this paper
• A mild acute hemolytic transfusion reaction in a patient with alloanti‐Ge3: a case report and review of the literature

  2011cites this paper
• Blood Transfusion in Sickle Cell Disease

  2011cites this paper
• Adults with Sickle‐Cell Disease: Implications of Increasing Longevity

  2011cites this paper
• The role of molecular immunohematology in sickle cell disease.

  2011cites this paper